Ard Tijsterman is an accomplished CEO with over 30 years of experience in the biotech industry, dedicated to advancing healthcare through innovative technologies. His passion lies in bridging the gap between technology development and market application. 

As an entrepreneur (co-founder of a diversity of companies: Tarpon Biosystems, Xendo, Biosanapharma, Ardent Biopharma) he has a proven track record of building and leading teams to bring breakthrough technologies to the end user, drug development projects to completion and the selling of assets/companies. 

Ard has an MSc in Biochemistry & Chemical Engineering with roots in process development, biopharmaceutical production, EU/US compliance, validation and drug development (RA, CMC & clinical).